IMGN Average Annual Return 10 Years
Growth of $10,000.00
Without Dividends Reinvested Into IMGN


Also see:
IMGN stock yearly return 2014
IMGN stock yearly return 2015
IMGN stock yearly return 2016
IMGN stock yearly return 2017
IMGN stock yearly return 2018
IMGN stock yearly return 2019
IMGN stock yearly return 2020
IMGN stock yearly return 2021
IMGN stock yearly return 2022
IMGN stock yearly return 2023
IMGN YTD return
Compare IMGN average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Start date: 02/13/2014
End date: 02/12/2024
Start price/share: $16.12
End price/share: $31.23
Dividends collected/share: $0.00
Total return: 93.73%
IMGN Average Annual Return: 6.83%
Starting investment: $10,000.00
Ending investment: $19,364.71
Years: 10.00


IMGN average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
ImmunoGen is a clinical-stage biotechnology company focused on developing the antibody-drug conjugates (ADCs). Co.'s main program is mirvetuximab, an ADC targeting folate receptor alpha, a cell-surface protein overexpressed in a number of epithelial tumors, including ovarian, endometrial, and non-small-cell lung cancers. Pivekimab sunirine is an ADC comprised of an antibody designed to target CD123 with site-specific conjugation to a DNA-alkylating payload of the IGN (indolinobenzodiazepine pseudodimer) class. Co.'s pipeline program, IMGC936, is an ADC that is designed to target ADAM9, an enzyme overexpressed in a range of solid tumors and implicated in tumor progression and metastasis. The IMGN average annual return 10 years is shown above.

The Average Annual Return on the IMGN average annual return 10 years page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether IMGN average annual return 10 years or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the IMGN average annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes

Email EnvelopeFree IMGN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
ImmunoGen (IMGN) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

IMMX Average Annual Return
IMNM Average Annual Return
IMNN Average Annual Return
IMRX Average Annual Return
IMUX Average Annual Return
IMVT Average Annual Return
INAB Average Annual Return
INBS Average Annual Return
INBX Average Annual Return
INCY Average Annual Return
More Healthcare companies »

★★★★ Based on a ranking of our entire coverage universe by highest ten year average annual return, ImmunoGen (IMGN) ranks within the highest 50% of all stocks whose returns we have reviewed.
What has the average annual return been for IMGN over the past ten years?
✔️Accepted answer: The ten year IMGN average annual return has been 6.83%.

What start date was used in your IMGN average annual return calculation?
✔️Accepted answer: The start date was 02/13/2014.

What end date was used in your IMGN average annual return calculation?
✔️Accepted answer: The end date was 02/12/2024.

If I had invested $10,000 into IMGN ten years ago, how much would I have today?
✔️Accepted answer: Today, as of 02/12/2024, you would have $19,364.71.

What does that work out to on a total return basis?
✔️Accepted answer: The IMGN ten year total return ending 02/12/2024 works out to 93.73%.


Also see:
IMGN stock yearly return 2014
IMGN stock yearly return 2015
IMGN stock yearly return 2016
IMGN stock yearly return 2017
IMGN stock yearly return 2018
IMGN stock yearly return 2019
IMGN stock yearly return 2020
IMGN stock yearly return 2021
IMGN stock yearly return 2022
IMGN stock yearly return 2023
IMGN YTD return
 

IMGN Average Annual Return 10 Years | www.AverageAnnualReturn.com | Copyright © 2021 - 2024, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.